Back to results
US 7,683,040 B2Granted
Intranasal formulation of rotigotine
AssigneeSRZ Properties, Inc.
InventorRobert Krämer
Life of this patent
Estimating the term…
Abstract
This invention pertains to a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and α-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5-1.5 mm2/s.
Claims17
A liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and α-cyclodextrin.
Dependencies are inferred from the claim text.